Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes.

MLA

Kuo, Selena Z., et al. “Clinical Utility of Liver Fat Quantification for Determining Cardiovascular Disease Risk among Patients with Type 2 Diabetes.” Alimentary Pharmacology & Therapeutics, vol. 58, no. 6, Sept. 2023, pp. 585–92. EBSCOhost, https://doi.org/10.1111/apt.17637.

APA

Kuo, S. Z., Cepin, S., Bergstrom, J., Siddiqi, H., Jung, J., Lopez, S., Huang, D. Q., Taub, P., Amangurbanova, M., & Loomba, R. (2023). Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes. Alimentary Pharmacology & Therapeutics, 58(6), 585–592. https://doi.org/10.1111/apt.17637

Chicago

Kuo, Selena Z., Sandra Cepin, Jaclyn Bergstrom, Harris Siddiqi, Jinho Jung, Scarlett Lopez, Daniel Q. Huang, Pam Taub, Maral Amangurbanova, and Rohit Loomba. 2023. “Clinical Utility of Liver Fat Quantification for Determining Cardiovascular Disease Risk among Patients with Type 2 Diabetes.” Alimentary Pharmacology & Therapeutics 58 (6): 585–92. doi:10.1111/apt.17637.